NKGen Biotech, Inc. Common Stock
NKGN · NASDAQ
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Market Cap | $18,890 | $11,012 | $30,694 | $42,775 |
| - Cash | $0 | $8 | $79 | $34 |
| + Debt | $0 | $30,740 | $28,117 | $22,214 |
| Enterprise Value | $18,890 | $41,744 | $58,732 | $64,955 |
| Revenue | $652 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $326 | $0 | $0 | -$326 |
| % Margin | 50% | – | – | – |
| EBITDA | -$15,266 | $7,402 | -$15,115 | -$3,987 |
| % Margin | -2,341.4% | – | – | – |
| Net Income | -$29,414 | $6,598 | -$16,088 | -$5,382 |
| % Margin | -4,511.3% | – | – | – |
| EPS Diluted | -0.77 | 0.15 | -0.67 | -0.25 |
| % Growth | -613.3% | 122.4% | -168% | – |
| Operating Cash Flow | -$6,953 | -$3,895 | -$5,999 | -$4,034 |
| Capital Expenditures | $17 | -$17 | $0 | $0 |
| Free Cash Flow | -$6,936 | -$3,912 | -$5,999 | -$4,034 |